HOME ZACKS RESEARCH PORTFOLIO COMMUNITY BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank     Equity Research     My Account     Help    
Zacks Method
Zacks Method for Trading Exploit the full force of Zacks Method to find your own market-beating stock picks today. New Year Sale ends soon! Learn more.
Quote:
Login
Search:

 Related Links
Zacks Equity Research
Reports: All Premium Content
Reports: Buys Premium Content
By Industry Premium Content
Upgrades Premium Content
Downgrades Premium Content
Bull of the Day
Bear of the Day
Industry Outlook
Analyst Blog
Performance
About Zacks Equity Research

Subscription Services
Product Guide
Top 10 Stocks
Zacks Premium
Zacks Elite
Method for Trading
Breakout Trader
Chart Patterns Trader
Growth Trader
Momentum Trader
Options Trader
Surprise Trader
Value Trader
Value Trader 2
Partner Newsletters
Special Reports
Research Wizard

Zacks Commentary: Zacks Analyst Interviews

  PRINTABLE VERSION  
A Pep Talk for the Market-Weary
With Charles Rotblut
Nov 13, 2008
Heaven knows we try to keep a sunny outlook on our portfolios and the market as a whole. But trying periods such as the one we have suffered through for the past week always seem to cloud our perspective. Zacks Senior Market Analyst Charles Rotblut, CFA joined us recently to give a much-needed pep talk.

What do you see as one of the biggest mistakes investors make in a market environment such as this?

During volatile market conditions, it’s not unusual for investors to abandon the very strategies that have worked for them over the long-term. Most often, this does more harm than good.

I’ve been very vocal in encouraging investors to look for fundamentally sound companies with rising earnings estimates that are trading at attractive valuations. That said, investors should stay proactive in managing their portfolios.

Specifically, investors should analyze every stock and mutual fund and ask whether they would buy it today if they did not already have money invested in it. If the answer is no, then they should consider selling those investments. It’s more prudent to take a known loss than to risk a potentially larger loss in the future.

Can you give us some perspective that we might not be seeing as we keep abreast of this bearish market?

Despite all of the headlines, the economy is in pretty good shape relative to past recessions. The unemployment rate of 6.5% is far below the typical 9% to 12% rates often seen during a recession. (During the 1930s, unemployment averaged close to 20%). Inventory levels are lean. And the Fed remains proactive.

Another positive is interest rates. European central banks issued aggressive rate cuts on Thursday, especially the Bank of England. The Federal Open Market Committee could lower its target rate for fed funds to below 1%. Combined with another potential stimulus package from the U.S., these actions should help lessen the severity of the global economic slump.

What would you say to those who are taking a more negative view of things?

Will there be more pain in the future? Yes. The unemployment rate typically rises even after the economy starts to rise. More people will lose their homes. And more businesses will fail.

However, recessions are comparatively short, and the economy will recover. The markets will recover. It’s just a matter of when, not if.

What particular companies are you bullish on currently?

Three stocks we’ve recently added to the [Zacks Focus List] portfolio are Axsys Technologies (AXYS), Bristol-Myers Squibb (BMY) and Petmed Express (PETS).

AXYS designs and manufactures camera systems, optical and motion control subsystems and related components. The products are used for both surveillance and next-generation weapons systems, areas that we think the Obama administration will continue to direct money towards. The company recently raised guidance and has a history of topping expectations.

BMY has one of the strongest growth rates among large-cap pharmaceutical companies. It also has a good mid-to-late stage pipeline. On a quantitative basis, the stock has an attractive valuation, earnings estimates are rising and the dividend yield is high.

PETS operates 1-800-PetMeds. PETS sells pharmaceutical and health products for dogs, cats and horses. The company is seeing a continued increase in reorder sales. We think it could get additional revenues as pet owners seek cheaper alternatives to their local vet. We also like the fact that operating margins have been and continue to expand.

Any final words for the market-weary?

The focus of investing ultimately is profits, and profits cannot be made by sitting out of the market. No one correctly times the market consistently. Furthermore, when big rallies occur, there is often no foreshadowing. Therefore, investors who do not need access to their investments within the next few years should consider maintaining some type of allocation to equities.

That said, there are timing risks in the current environment. A more conservative strategy is dollar-cost averaging. This strategy involves buying shares in certain stock over a period of months as opposed to a single purchase. An investor may not get the lowest price for all his transactions, but he also won’t run the risk of buying a full position (e.g. 100 shares) on the wrong day.

Keep in mind we’ve been in this situation before. During the latter half of the 19th century, a railroad bubble led to a credit crunch and economic problems. Yet the U.S. came out of it and reached an even higher level of prosperity.

Most importantly, stocks are the most effective way to build long-term wealth. Though there will be bear markets, bull market cycles tend to be more powerful and last longer.

Successful investors, such as Warren Buffet, never stop looking at stocks – and neither should individual investors.

Charles Rotblut, CFA is the Senior Market Analyst for Zacks.com.

       Email        Feedback          Print       


About Zacks Analyst Interviews

Zacks Equity Research employs 50 stock analysts who are experts in the industries they cover. In these articles you will discover our analyst's insights on key industries in the news along with their favorite stocks to buy and sell now.

Zacks Equity Research Home Page

ZACKS COMMENTARY: ZACKS ANALYST INTERVIEWS ARCHIVE

Pharmaceuticals
With Jason Napodano
Jan 06, 2009
We are generally positive on the pharmaceutical industry heading into 2009. We expect the majority of stocks to fair far better in 2009 than they did in 2008, based on a number of attributes. We like PFE, JNJ, BMY, ABT and ISIS.

U.S. Insurance Industry
With Neena Mishra
Jan 05, 2009
Ongoing turmoil in the financial markets has resulted in a highly challenging environment for the U.S. insurance industry, a trend that is expected to continue in 2009. We also expect further consolidation in the industry. We have Buys on AMSF and PRE, but Sells on PMI, PRS and HIG.

Machinery & Industrials
With Mario Ricchio
Jan 01, 2009
As foreign economies deal with weaker exports to the U.S and Europe, industrial customers are cutting back on capital spending. We cite Freeport McMoRan.

Hotels & Lodging
With Sean P. Smith
Dec 31, 2008
As the recession continues, hotel companies that are able to limit the degree to which room rates are discounted will be in the best position to benefit once the economic environment improves. We discuss Starwood and Marriott.

Restaurant Industry
With Ann Northrop
Dec 30, 2008
Restaurants are typically early-cycle stocks, bottoming six-to-nine months before a turn in the economy. With that in mind, it appears that investors expect restaurant traffic to bottom in the June-to-September time frame. We discuss McDonald's, Yum! Brands and Jamba, Inc.


 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research